[Clinical trial of a Plantago major preparation in the treatment of chronic bronchitis].
Plantago major, according to literature data, has expectorant, antiphlogistic, pain-relieving effect. The experimental studies confirmed a spastic effect upon the smooth musculature of bronchi as well. Twenty five patients with chronic bronchitis were examined, with or without spastic character, with light and moderately severe deviations in ventilation indices. The treatment period was 25-30 days. A rapid effect on subjective complaints and objective findings was obtained in 80 per cent. Some indices of external respiration were favourably affected. The preparation is with a good tolerance, with no toxic effect on gastrointestinal tract, liver, kidneys, hemopoiesis.
D000328:Adult; D000368:Aged; D000996:Antitussive Agents / Q000627:therapeutic use; D001991:Bronchitis / Q000150:complications / Q000188:drug therapy*; D001993:Bronchodilator Agents; D002908:Chronic Disease; D005100:Expectorants / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010936:Plant Extracts / Q000009:adverse effects / Q000627:therapeutic use*; D010943:Plantago; D010946:Plants, Medicinal; D012131:Respiratory Insufficiency / Q000150:complications
D000996:Antitussive Agents; D001993:Bronchodilator Agents; D005100:Expectorants; D010936:Plant Extracts
Klinichno izpitvane na preparat ot Plantago major za lechenie na khronichni bronkhiti.